Synthesis, Characterization, Molecular Docking Study and Biological Evaluation of Novel 1,3,4-Thiadiazole-Based Heterocycles as Potential Anticancer and Antioxidant Agents. [PDF]
El-Metwaly NM +7 more
europepmc +1 more source
Computational Design and Theoretical Evaluation of Novel Heterocyclic Energetic Materials Based on 5-H-Imidazo-[4,5-c]-Pyridazine and 1,2,4-Triazolo-[4,3-a]-Pyrazine Scaffolds. [PDF]
da Silva LA +3 more
europepmc +1 more source
Recent advances in synthesis and medicinal chemistry of pyrrolodiazepines. [PDF]
Zhou M, Wang S.
europepmc +1 more source
Unlocking the Potential of Isatin Scaffolds in Acetylcholinesterase Inhibition. [PDF]
Tharwat T +3 more
europepmc +1 more source
Design, synthesis, <i>in silico</i> studies, and biological evaluation of tosyl-substituted thiazoles, thiazolidin-4-ones, and chromenes as potential anticancer agents. [PDF]
Said GE +4 more
europepmc +1 more source
To make exceptionally effective drugs, thinking “outside the binding site” is required. This work reveals that counterintuitive targeting of a kinase‐conserved region can lead to highly selective binding. Inhibitor discovery coupled to x‐ray crystallography shows that a network of noncanonical interactions and long‐range effects of distant unique amino
Nico J. Seidler +20 more
wiley +1 more source
Silver-catalyzed anionic [3 + 2] cycloaddition of benzyl isocyanides with polyfluoroalkylchromones and pyrones: direct synthesis of 2-arylpyrroles. [PDF]
Kochnev IA, Barkov AY.
europepmc +1 more source
Deciphering the Medicinal Chemistry Aspects of Akt Inhibitors for the Management of Cancer: Structure-Activity Relationship Frameworks, Landscapes, and Optimization Approaches. [PDF]
Dhangar MS, Palkar MB.
europepmc +1 more source
We introduce the Aza‐Büchner–Curtius–Schlotterbeck (ABCS) reaction: A mild, catalyst‐free method for homologating aryl imines. Diverging from the traditional BCS mechanism, the diazo intermediate undergoes selective C─C insertion to form an all‐carbon quaternary center.
Simon O. Angerer +6 more
wiley +1 more source
Structure-Activity Relationship for Inflammasome Inhibition by Thiomuscimol. [PDF]
Anderson MJ +4 more
europepmc +1 more source

